Hypoxia modifies the effect of PDGF on glycosaminoglycan synthesis by primary human lung cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 279, Issue 5 23-5, 2000, Pages

  Papakonstantinou, Eleni ^a   Karakiulakis, George ^a   Tamm, Michael ^b   Perruchoud, André P ^b   Roth, Michael ^b,c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Platelet derived growth factor; Primary lung fibroblasts; Primary lung vascular smooth muscle cells; Pulmonary fibrosis; Pulmonary hypertension

Indexed keywords

CHONDROITIN SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HYALURONIC ACID; PLATELET DERIVED GROWTH FACTOR;

ARTICLE; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; HUMAN CELL; HYPOXIA; LUNG ALVEOLUS CELL; LUNG DISEASE; LUNG FIBROBLAST; MOLECULAR SIZE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0033725251     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2000.279.5.l825     Document Type: Article

References (36)

1. Increased PMN adherence on endothelial cells after hypoxia: Involvement of PAF, CD 18/CD11B, and ICAM
2. A modified uronic acid carbazole reaction
3. Glycosaminoglycan and collagen synthesis in N-nitroso-N-methylurethane induced pulmonary fibrosis
4. Glycosaminoglycan synthesis in explants derived from bleomycin-treated fibrotic hamster lungs
5. Smooth muscle cells isolated from discrete compartments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities
6. Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level
7. Partial reversal of hypoxic pulmonary hypertension by heparin
8. Effect of hypoxia on release of IL-1 and TNF by human alveolar macrophages
9. Cell surface glycosaminoglycans
10. Effects of hypoxia on proteoglycan production by bovine pulmonary artery endothelial cells
11. Effects of hypoxia on heparan sulfate in bovine aortic and pulmonary artery endothelial cells
12. Medical management of primary pulmonary hypertension
13. Hypoxia and endothelial-smooth muscle cell interactions in the lung
14. In vitro effects of pentoxifylline on smooth muscle cell migration and blood monocyte production of chemotactic activity for smooth muscle cells: Potential therapeutic benefit in the adult respiratory distress syndrome
15. Hypoxia-mediated induction of acidic-basic fibroblast growth factor and platelet derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells
16. Augmentation of fibroblast proliferation by bleomycin
17. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is down-regulated by corticosteroids
18. A novel class of adhesion acidic glycans in sea urchin embryos. Isolation, characterization and immunological studies during early embryonal development
19. A 340 kDa hyaluronic acid secreted by human vascular smooth muscle cells regulates their proliferation and migration
20. Platelet-derived growth factor stimulates the secretion of hyaluronic acid by proliferating human vascular smooth muscle cells
21. Isolation and characterization of a new class of acidic glycans implicated in sea urchin embryonal cell adhesion
22. The differential distribution of hyaluronic acid in the layers of human atheromatic aortas is associated with vascular smooth muscle cell proliferation and invasion
23. Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function
24. Hypoxia induces capillary network formation in cultured bovine pulmonary microvessel endothelial cells
25. Expression of the low density lipoprotein receptor and 3-hydroxy-3-methylgluatryl coenzyme A reductase genes are stimulated by recombinant platelet-derived growth factor isoforms
26. Cell cultures from cryopreserved human lung tissue
27. Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase
28. The distribution of the glycosaminoglycans in the anatomic components of the lung and the changes in the concentration of these macromolecules during development and aging
29. Determination of protein bound carbohydrate in serum by a modified anthron method
30. Effect of aerosol heparin on the development of hypoxic pulmonary hypertension in the guinea pig
31. Hypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet activating factor and platelet-derived growth factor in primary human lung cells
32. Mechanism of impaired local hyaluronan turnover in bleomycin-induced lung injury in rat
33. Characterization of the mechanism involved in bleomycin-induced increased hyaluronan production in rat lung
34. Inhibition of hypoxic pulmonary hypertension by heparins of differing in vitro antiproliferative potency
35. CD44 positive macrophages take up hyaluronan during lung development
36. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension